Ensign Group Inc (ENSG) cash flow statement

NASDAQ · Health Care

$186.02 -1.17% Close Nov 17, 2026 Live

TrendArc score 70 of 100 · Health 7.1 · Momentum 7.1 · Moat 6.2 · scored Nov 17, 2026 · How the score works

Free cash flow, fiscal year to December 31, 2025

$371 million

up 96.2% from the year before

Ensign Group generated $371 million of free cash flow in the fiscal year to December 2025: $564 million of cash from operations less $194 million of capital spending. That was 7.3% of revenue, against 4.4% the year before. Over the last four quarters, to September 30, 2026, it was $510 million.

What stands out

  • Cash dividends paid rose in each of the last five fiscal years, from $11 million to $14 million in total.

Each sentence is written by a fixed rule from the figures on this page.

Free cash flow and net income, the last 6 fiscal years

$100M$200M$300M$400M202020212022202320242025$298MFree cash flow $371MNet income $344M$100M$200M$300M$400M202120232025Free cash flow $371MNet income $344M

Fiscal years, each labelled by the calendar year it ended in. Every figure is in the statement below.

Where the cash wentFiscal year to December 31, 2025

  1. Cash from operations 564
  2. Capital spending -194
  3. Free cash flow 371
  4. Businesses bought and sold, net -323
  5. Investments bought and sold, net -11
  6. Net share issuance 8
  7. Dividends -14
  8. Debt and other 10
  9. Net change in cash 39

In millions of US dollars. Outflows are grey, not red: a buyback is not a loss. "Debt and other" closes the gap to the reported change in cash. Buying marketable securities moves cash into short-term investments; the balance sheet shows both.

Cash flow statement, the last 6 fiscal years

In millions of US dollars. Each column is a fiscal year, named by the month it ended; the first column adds up the last four quarters. Cash paid out is a negative number.
Fiscal year toLast 4 quarters
to Sep 2026
Dec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Operating activities
Net income344298209225195170
Depreciation and amortisation1048472635655
Stock-based pay62483631231915
Working capital and other items68-7164-386133
Cash from operations696564347377273276373
Investing activities
Capital spending-186-194-158-106-88-168-75
Businesses bought and sold, net-323-157-69-93-614
Investments bought and sold, net-11-79-11-7-71
Cash from investing-513-390-183-186-174-59
Financing activities
Debt issued or repaid, net-4-4-4-7-61-111
Shares issued less bought back-2182116-19-3-13
Dividends paid-15-14-14-13-12-12-11
Cash from financing-12-2-1-32-76-137
Net change in cash39-451935426177
Free cash flow
Free cash flow510371189270185108298
Free cash flow margin9.0%7.3%4.4%7.3%6.1%4.1%12.4%
Free cash flow per share$6.30$3.24$4.72$3.25$1.90$5.34

Shares issued less bought back is the cash from shares sold less the cash paid for shares bought back (negative when more was bought back), and includes tax withheld when employees' shares vest. Working capital and other items is cash from operations less net income, depreciation and amortisation, and stock-based pay (calculated by TrendArc). Company filings as standardised by Tiingo; calculations by TrendArc. Rebuilt nightly.

Ensign Group against its peers

CompanyFiscal year toFree cash flowFree cash flow margin
Bio-TechneTECH Jun 2026$263M21.7%
InsuletPODD Dec 2025$350M12.9%
Align TechnologyALGN Dec 2025$491M12.2%
Cooper Companies (The)COO Oct 2025$434M10.6%
DaVitaDVA Dec 2025$1.31B9.6%
Ensign GroupENSG Dec 2025$371M7.3%
Universal Health ServicesUHS Dec 2025$825M4.7%
Kymera TherapeuticsKYMR Dec 2025-$234M-597.6%
Peer median10.6%

Each company's newest fiscal year; some end in other months. The peers are the stock card's peer group.

Next

Follow Ensign Group with a free account.

A watchlist, price alerts and saved chart layouts. No card needed.

Sign up free

No forecast, no recommendation. This page describes Ensign Group Inc from published data; it is not advice to buy, sell or hold any security.

Figures as of the close on Nov 17, 2026 unless a row says otherwise. Prices are split adjusted; returns include dividends reinvested. Data may be delayed. See the disclaimer and how TrendArc works.

The TrendArc score, from 0 to 100, combines three pillars measured from published data, Health (business quality over the last twelve months), Momentum (the price against its moving averages, its 52-week high and the market) and Moat (durability over five years), with the share price's long-run trend. It describes the company as it stands today. It is not a forecast or a recommendation.